About MicrobeDx
MicrobeDx is a company based in Los Angeles (United States) founded in 2015. MicrobeDx has raised $6.21 million across 5 funding rounds from investors including HHS. MicrobeDx operates in a competitive market with competitors including Cepheid, Biological Dynamics, Karius, Day Zero Diagnostics and OpGen, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.21 M (USD)
in 5 rounds
-
Latest Funding Round
$300 K (USD), Series A
Dec 29, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MicrobeDx
MicrobeDx has successfully raised a total of $6.21M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $300 thousand completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MicrobeDx
MicrobeDx has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for MicrobeDx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MicrobeDx
Investment portfolio details for MicrobeDx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MicrobeDx
Detailed financials for MicrobeDx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Microbedx Comparisons
Peer comparison for MicrobeDx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MicrobeDx
MicrobeDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Biological Dynamics, Karius, Day Zero Diagnostics and OpGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Food safety technologies are provided for pathogen identification.
|
Detailed competitors of MicrobeDx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Microbedx
Complete news archive for MicrobeDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MicrobeDx
MicrobeDx was founded in 2015 and raised its 1st funding round 2 years after it was founded.
MicrobeDx is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
MicrobeDx is a funded company, having raised a total of $6.21M across 5 funding rounds to date.
MicrobeDx was founded in 2015 and is headquartered in Los Angeles, United States, operating in the biotechnology sector focused on diagnostic tools. A platform is developed by the company that employs hybridization and capture of ribosomal RNA for bacterial species identification without PCR, integrated with phenotypic testing for antibiotic susceptibility. Results for species identification are achieved in 30-45 minutes, while susceptibility testing is completed within 3 hours.
MicrobeDx's top competitors include Cepheid, Clear Labs and Day Zero Diagnostics.
MicrobeDx has 1 investor. Key investors include HHS.